The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial

Jinlan Liao, Amy Kang, Chao Xia, T. Kue Young, Gian Luca Di Tanna, Clare Arnott, Carol A. Pollock, Arun V. Krishnan, Rajiv Agarwal, George L. Bakris, David M. Charytan, Dick de Zeeuw, Hiddo J.L. Heerspink, Adeera Levin, Bruce Neal, David C. Wheeler, Hong Zhang, Bernard Zinman, Kenneth W. Mahaffey, Vlado Perkovic, Meg Jardine, Brendan Smyth